However, whether there are key methylation sites in this regulatory network that directly regulate PGAM1 expression, whether the detection of PGAM1 hypomethylation can be used as a tumor marker, and the effect of altering its methylation status on the behavior of tumors need to be further elucidated in the future by molecular editing and phenotyping methods. The gene discussed is PGAM1; the disease is neoplasm.